Your browser doesn't support javascript.
loading
Vascular cognitive impairment and dementia: a narrative review.
Jiménez-Ruiz, Amado; Aguilar-Fuentes, Victor; Becerra-Aguiar, Naomi Nazareth; Roque-Sanchez, Ivan; Ruiz-Sandoval, Jose Luis.
Affiliation
  • Jiménez-Ruiz A; Stroke & Cerebrovascular Disease Clinic, Hospital Civil Fray Antonio Alcalde, Neurology Department, Guadalajara, Jalisco, Mexico.
  • Aguilar-Fuentes V; Stroke & Cerebrovascular Disease Clinic, Hospital Civil Fray Antonio Alcalde, Neurology Department, Guadalajara, Jalisco, Mexico.
  • Becerra-Aguiar NN; Stroke & Cerebrovascular Disease Clinic, Hospital Civil Fray Antonio Alcalde, Neurology Department, Guadalajara, Jalisco, Mexico.
  • Roque-Sanchez I; Stroke & Cerebrovascular Disease Clinic, Hospital Civil Fray Antonio Alcalde, Neurology Department, Guadalajara, Jalisco, Mexico.
  • Ruiz-Sandoval JL; Stroke & Cerebrovascular Disease Clinic, Hospital Civil Fray Antonio Alcalde, Neurology Department, Guadalajara, Jalisco, Mexico.
Dement Neuropsychol ; 18: e20230116, 2024.
Article in En | MEDLINE | ID: mdl-39318380
ABSTRACT
Vascular cognitive impairment (VCI) is the second most common cause of cognitive impairment after Alzheimer's disease. The VCI spectrum involves a decline in cognition attributable to vascular pathologies (e.g., large infarcts or hemorrhages, microinfarcts, microbleeds, lacunar infarcts, white matter hyperintensities, and perivascular space dilation). Pathophysiological mechanisms include direct tissue injury, small vessel disease, inflammaging (inflammation + aging), atrophy, and altered neurotransmission. VCI is diagnosed using distinct clinical and radiological criteria. It may lead to long-term disability and reduced quality of life. An essential factor for reducing cognitive impairment incidence is preventing stroke by managing traditional and non-traditional cerebrovascular risk factors. This article reviews the spectrum of VCI, epidemiology, risk factors, pathophysiology, diagnosis, available treatment, and preventive strategies.
RESUMO
O comprometimento cognitivo vascular (CCV) é a segunda causa mais comum de comprometimento cognitivo depois da doença de Alzheimer. O espectro do CCV envolve um declínio na cognição atribuível a patologias vasculares (por exemplo, grandes infartos ou hemorragias, microinfartos, micro-hemorragias, infartos lacunares, hiperintensidades da substância branca e dilatação do espaço perivascular). Os mecanismos fisiopatológicos incluem lesão tecidual direta, doença de pequenos vasos, inflammaging (inflamação+envelhecimento), atrofia e neurotransmissão alterada. O CCV é diagnosticado usando critérios clínicos e radiológicos distintos. Pode levar à incapacidade a longo prazo e à redução da qualidade de vida. Um fator essencial para reduzir a incidência de comprometimento cognitivo é prevenir o acidente vascular cerebral através do manejo dos fatores de risco cerebrovasculares tradicionais e não tradicionais. Este artigo revisa o espectro do CCV, epidemiologia, fatores de risco, fisiopatologia, diagnóstico, tratamento disponível e estratégias preventivas.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Dement Neuropsychol Year: 2024 Document type: Article Affiliation country: Mexico Country of publication: Brazil

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Dement Neuropsychol Year: 2024 Document type: Article Affiliation country: Mexico Country of publication: Brazil